Skip to main content
. 2014 Mar 22;5(9):2575–2587. doi: 10.18632/oncotarget.1842

Figure 1. (A) EYA2 expression by real-time PCR in normal HPDE cells and nine pancreatic cancer cell lines.

Figure 1

(B-E) Representative figures of immunohistochemical staining of EYA2 with tissue microarrays. (B) Transition from normal ductal epithelium (arrows) to PanIN1. PanIN1 shows a decreased EYA2 expression. (C-E) Pancreatic ductal adenocarcinomas show a decrease or complete loss of EYA2 expression compared to entrapped normal ductal or acinar cells (arrows). Magnification: 10X.